Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Burkhoff

Showing results (331-340 of 484) with videos related to

Pageof 49
Sort By:
Journal of the American Heart Association|May 15, 2025
Impact of Mean Blood Pressure Profiles in Percutaneous Left Ventricular Assist Device-Supported High-Risk Percutaneous Coronary Intervention: The PROTECT III StudyGuillaume Bonnet, Karl-Philipp Rommel, Batla Falah, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 21, 2021
Research Priorities in Lymphatic Interventions: Recommendations from a Multidisciplinary Research Consensus PanelMaxim Itkin, Stanley G Rockson, Marlys H Witte, et al.
JACC. Cardiovascular Interventions|August 23, 2023
Stressed Blood Volume in Severe Tricuspid Regurgitation: Implications for Transcatheter TreatmentKarl-Philipp Rommel, Christian Besler, Matthias Unterhuber, et al.
JAMA Cardiology|December 29, 2021
Remote Cardiac Monitoring in Patients With Heart Failure: A ReviewPeter J Kennel, Hannah Rosenblum, Kelly M Axsom, et al.
Journal of Cardiac Failure|January 2, 2022
Racial Differences in Val122Ile-Associated Transthyretin Cardiac AmyloidosisJaya Batra, Hannah Rosenblum, Francesco Cappelli, et al.
The American Journal of Cardiology|February 15, 2026
Estimated Stressed Blood Volume in Patients with Cardiac AmyloidosisSimon Vanhentenrijk, Silvio Nunes Augusto, Pieter Martens, et al.
European Journal of Heart Failure|August 11, 2025
A multicentre, randomized, double-blind, active and placebo-controlled study of pecavaptan, a dual V1a/V2 vasopressin receptor antagonist, in patients with acute heart failure: The AVANTI trialJames E Udelson, Steven R Goldsmith, Daniel Burkhoff, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 10, 2024
Left ventricular hemodynamics with veno-arterial extracorporeal membrane oxygenationRajat Kalra, Tamas Alexy, Jason A Bartos, et al.
European Journal of Heart Failure|January 18, 2019
Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fractionStefan D Anker, Martin Borggrefe, Hans Neuser, et al.
Journal of the American College of Cardiology|April 1, 2026
Cardiogenic Shock Survivorship: A Multidisciplinary Approach Across the Continuum of CareVanessa Blumer, Shashank S Sinha, Anthony P Carnicelli, et al.
Pageof 49

Showing results (331-340 of 484) with videos related to

Sort By:
Pageof 49
Journal of the American Heart Association|May 15, 2025
Impact of Mean Blood Pressure Profiles in Percutaneous Left Ventricular Assist Device-Supported High-Risk Percutaneous Coronary Intervention: The PROTECT III StudyGuillaume Bonnet, Karl-Philipp Rommel, Batla Falah, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 21, 2021
Research Priorities in Lymphatic Interventions: Recommendations from a Multidisciplinary Research Consensus PanelMaxim Itkin, Stanley G Rockson, Marlys H Witte, et al.
JACC. Cardiovascular Interventions|August 23, 2023
Stressed Blood Volume in Severe Tricuspid Regurgitation: Implications for Transcatheter TreatmentKarl-Philipp Rommel, Christian Besler, Matthias Unterhuber, et al.
JAMA Cardiology|December 29, 2021
Remote Cardiac Monitoring in Patients With Heart Failure: A ReviewPeter J Kennel, Hannah Rosenblum, Kelly M Axsom, et al.
Journal of Cardiac Failure|January 2, 2022
Racial Differences in Val122Ile-Associated Transthyretin Cardiac AmyloidosisJaya Batra, Hannah Rosenblum, Francesco Cappelli, et al.
The American Journal of Cardiology|February 15, 2026
Estimated Stressed Blood Volume in Patients with Cardiac AmyloidosisSimon Vanhentenrijk, Silvio Nunes Augusto, Pieter Martens, et al.
European Journal of Heart Failure|August 11, 2025
A multicentre, randomized, double-blind, active and placebo-controlled study of pecavaptan, a dual V1a/V2 vasopressin receptor antagonist, in patients with acute heart failure: The AVANTI trialJames E Udelson, Steven R Goldsmith, Daniel Burkhoff, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 10, 2024
Left ventricular hemodynamics with veno-arterial extracorporeal membrane oxygenationRajat Kalra, Tamas Alexy, Jason A Bartos, et al.
European Journal of Heart Failure|January 18, 2019
Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fractionStefan D Anker, Martin Borggrefe, Hans Neuser, et al.
Journal of the American College of Cardiology|April 1, 2026
Cardiogenic Shock Survivorship: A Multidisciplinary Approach Across the Continuum of CareVanessa Blumer, Shashank S Sinha, Anthony P Carnicelli, et al.
Pageof 49